Joshua Reed
Vermogen: 819 099 $ op 30-09-2026
Vermogen: 819 099 $ op 30-09-2026
Mr. Joshua Reed is a Chief Financial Officer & Senior Vice President at Alkermes Plc and an Independent Director at Scholar Rock Holding Corp.
He is on the Board of Directors at Scholar Rock Holding Corp.
Mr. Reed was previously employed as a Chief Financial & Accounting Officer by Omega Therapeutics, Inc., a Chief Financial Officer & Treasurer by Aldeyra Therapeutics, Inc., a Vice President & Head-Finance Operations by Bristol Myers Squibb Co., and a Vice President-Strategic Business Development by JPMorgan Chase & Co. He received his undergraduate degree from Rutgers State University of New Jersey and an MBA from Stephen M.
Ross School of Business.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-07-2026 | 12.679 ( 0,01% ) | 612 649 $ | 30-09-2026 | |
| 08-10-2026 | 5.095 ( 0% ) | 206 449 $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Directeur/Bestuurslid | 18-03-2021 |
| ALKERMES PLC | Financieel Directeur/CFO | 15-09-2025 |
| Bedrijven | Functie | Einde |
|---|---|---|
| OMEA THER | Financieel Directeur/CFO | 31-05-2024 |
| ALDEYRA THERAPEUTICS, INC. | Financieel Directeur/CFO | 10-05-2022 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-07-2018 |
| JPMORGAN CHASE & CO. | Corporate Officer/Principal | 01-01-2005 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 8 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
JPMorgan Chase & Co.
JPMorgan Chase & Co. Major BanksFinance Provides banking, asset management, investment banking, credit card and mortgage services | Finance |
Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for eye diseases | Health Technology |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stephen M. Ross School of Business
Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alkermes Plc
Alkermes Plc Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products to treat neurodegenerative disorders and cancer | Health Technology |
Scholar Rock Holding Corp.
Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
Omega Therapeutics, Inc.
Omega Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for general and rare genetic diseases, immunology, inflammation, oncology and metabolic diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau